Low-dose UVA1 Radiation in Cutaneous Lupus Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01776190|
Recruitment Status : Recruiting
First Posted : January 28, 2013
Last Update Posted : February 28, 2022
|Condition or disease||Intervention/treatment||Phase|
|Cutaneous Lupus Erythematosus||Device: UVA1 radiation treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Low-dose UVA1 Radiation in Cutaneous Lupus Patients|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||September 2022|
|Estimated Study Completion Date :||September 2022|
Experimental: UVA1 treatment
Low-dose UVA1 will be applied to active cutaneous lupus lesions three times a week for 10 weeks.
Device: UVA1 radiation treatment
- CLASI activity score [ Time Frame: 18 weeks ]This is a measure of the amount of skin disease activity in cutaneous lupus patients.
- Lupus flares [ Time Frame: 18 weeks ]We are determining whether one has a cutaneous lupus or systemic lupus flare with this treatment. Measurements using the Cutaneous Lupus Activity and Severity Index and Systemic Lupus Erythematosus Disease Activity Index will be used to monitor disease activity and help determine flares.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01776190
|Contact: Benjamin F Chong, MD, MSCSemail@example.com|
|United States, Texas|
|University of Texas Southwestern Medical Center||Recruiting|
|Dallas, Texas, United States, 75390-9069|
|Contact: Benjamin F Chong, MD, MSCS 214-648-3427 firstname.lastname@example.org|
|Principal Investigator:||Benjamin F Chong, MD, MSCS||University of Texas Southwestern Medical Center|